Astellas Venture Management LLC, a venture capital subsidiary of Astellas Pharma Inc., and LabCentral are collaborating on their latest “Golden Ticket Competition.” A Golden Ticket offers entrepreneurial scientists or emerging biotechnology start-ups one-year usage of LabCentral’s state-of-the-art lab facility, as well as access to Astellas’ research and development (R&D) capabilities and business leaders.